Drug Trial Radar · NCT07450521
Evaluation of MTX-463 Administered Subcutaneously in Healthy Adult Males
Last checked: Nov 19, 2026Latest source record: Mar 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
8
Actual
Start
Feb 18, 2026
Primary completion
Mar 11, 2026
Study completion Mar 11, 2026
Sponsor
- Lead sponsor
- Mediar TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Mar 4, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Other
- FDA-regulated drug
- Yes
- Who can join
- Male only, from 18 years, up to 60 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
A randomized, double-blind, placebo-controlled, study to assess the safety, tolerability, and PK of MTX-463 when administered via SC injection in healthy adult males.
Conditions
- Healthy Adult Male
Interventions
MTX-463Biological
MTX-463 is an immunoglobin G1 (IgG1) monoclonal antibody directed against WNT-inducible signaling pathway protein 1 (WISP1). WISP1 (aka CCN-4) is a matricellular protein that appears to be upregulated locally in response to certain chronic diseases, including IPF, and malignancies.
PlaceboOther
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- PK will be evaluated by area under the plasma concentration versus time curve from time zero to t (AUC0-t) of MTX-463Time frame: 22 Days
- PK will be evaluated by Maximum Observed Plasma Concentration (Cmax) of MTX-463Time frame: 22 Days
- Comparisons of Maximum Observed Plasma Concentration (Cmax) of MTX-463 will be made to historical single-dose 4-mg/kg IV data.Time frame: 22 Days
- Comparisons of area under the plasma concentration versus time curve from time zero to t (AUC0-t) of MTX-463 will be made to historical single-dose 4-mg/kg IV data.Time frame: 22 Days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Icon Slc Cru
Salt Lake City, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.